Login
institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published • loading... • Updated

Monoclonal Antibody Shows Promise in Cardiogenic Shock

Summary by Medscape
Three critically ill patients treated with procizumab experience a full reversal of cardiogenic shock in 48 hours.

2 Articles

MedscapeMedscape

Monoclonal Antibody Shows Promise in Cardiogenic Shock

Three critically ill patients treated with procizumab experience a full reversal of cardiogenic shock in 48 hours.

·United States
Read Full Article
pharmatimes.compharmatimes.com

4TEEN4 begins trial of antibody therapy for cardiogenic shock

First patient dosed in phase 1b/2a study of procizumab

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

pharmatimes.com broke the news in on Wednesday, July 23, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Medical icon

Medical

You have read 1 out of your 5 free daily articles.

News
For You
SearchBlindspotLocal